Shuttle Pharmaceuticals Inc
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clini… Read more
Market Cap & Net Worth: Shuttle Pharmaceuticals Inc (SHPH)
Shuttle Pharmaceuticals Inc (NASDAQ:SHPH) has a market capitalization of $3.35 Million ($3.35 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #34852 globally and #11368 in its home market, demonstrating a 4.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shuttle Pharmaceuticals Inc's stock price $1.03 by its total outstanding shares 3254422 (3.25 Million).
Shuttle Pharmaceuticals Inc Market Cap History: 2015 to 2026
Shuttle Pharmaceuticals Inc's market capitalization history from 2015 to 2026. Data shows growth from $1.95K to $3.35 Million (112.54% CAGR).
Index Memberships
Shuttle Pharmaceuticals Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #876 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2761 of 3165 |
Weight: Shuttle Pharmaceuticals Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Shuttle Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shuttle Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SHPH by Market Capitalization
Companies near Shuttle Pharmaceuticals Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Shuttle Pharmaceuticals Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Shuttle Pharmaceuticals Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Shuttle Pharmaceuticals Inc's market cap moved from $1.95K to $ 3.35 Million, with a yearly change of 112.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.35 Million | -42.78% |
| 2025 | $5.86 Million | +109.55% |
| 2024 | $2.80 Million | -76.40% |
| 2023 | $11.85 Million | -76.79% |
| 2022 | $51.03 Million | +3919900.00% |
| 2017 | $1.30K | -63.64% |
| 2016 | $3.58K | +83.33% |
| 2015 | $1.95K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shuttle Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.35 Million USD |
| MoneyControl | $3.35 Million USD |
| MarketWatch | $3.35 Million USD |
| marketcap.company | $3.35 Million USD |
| Reuters | $3.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.